Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

Authors :: Cutsem, E. Van
Dicato, M.
Arber, N.
Berlin, J.
Cervantes, A.
Ciardiello, F.
Gramont, A. De
Diaz-Rubio, E.
Ducreux, M.
Geva, R.
Glimelius, B.
Glynne-Jones, R.
Grothey, Axel
Gruenberger, T.
Haller, D.
Haustermans, K.
Labianca, R.
Lenz, H. J.
Minsky, B.
Nordlinger, B.
Ohtsu, A.
Pavlidis, Nicholas
Rougier, P.
Schmiegel, W.
Velde, C. Van de
Schmoll, H. J.
Sobrero, A.
Tabernero, Josep
Pavlidis, Nicholas [0000-0002-2195-9961]
Source :: Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.
Abstract: The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC. 21 Suppl 6 vi1 10

Full Text Access

Tools